Drug Firm Wins Lawsuit Against SFDA’s Drug Clinical Trial Halt
This article was originally published in PharmAsia News
Executive Summary
A judge ruled in favor of Guangzhou Baisai Luoyaoye Pharmaceutical Co. Ltd., which sued SFDA over a decision to halt development of its hypertension treatment.